The World Molecular Imaging Society (WMIS) will hold its sixth annual meeting in Savannah, Georgia.
The four-day forum from 18 September to 21 September will feature advances in molecular multimodality imaging with a focus on discovery, preclinical, and translational research. It will also highlight first-in-human studies geared toward diagnostics and targeted therapy.
This year's program will include 168 oral presentations and 35 papers covering five categories:
- Chemistry and imaging probes
- First-in-human and clinical studies
- Preclinical cell and tissue-level studies
- Preclinical in vivo studies
- Technology and software development
The meeting will also host more than 60 industry exhibitors.
